Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Energy Development Program Implementation Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Clinical research S. 1675 "Improving Access to Clinical Trials Act" passage & implementation; Health care reform & implementation including B. Marshalls PCORI nomination, comment submissions; FDA funding & processes; NIH funding & processes; CMS coverage decisions including: home IV & DME; 340B Drug Pricing Program; FDA drug approval process
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · third_quarter · Q3
Clinical research S. 1675 "Improving Access to Clinical Trials Act" passage & implementation; Health care reform & implementation including B. Marshalls PCORI nomination, comment submissions; FDA funding & processes; NIH funding & processes; CMS coverage decisions including: home IV & DME; 340B Drug Pricing Program; FDA drug approval process
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
Source: Senate LDA